SMARCA4 and neoplasm of thorax: Clinicians should maintain a high index of suspicion for SMARCA4 deficiency in male smokers presenting with undifferentiated thoracic tumors but also broaden differential diagnoses to include SMARCA4-altered disease in extrapulmonary sites.